Newsroom | 5632 results

Sorted by: Latest

Alternative Medicine
-

Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide...
-

The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “Notes”), which are parties to t...
-

Groundbreaking Clinical Study Reveals Promising Evidence for VIVAZEN®’s Kratom Extracts

PHOENIX--(BUSINESS WIRE)--VIVAZEN® proudly announces the results of a pioneering 28-day clinical study evaluating the safety and tolerability of its proprietary kratom extracts. The findings, presented by Dr. Jenelle Patterson of Gowling WLG, at the University of Florida Fifth Scientific Kratom Symposium, reinforce VIVAZEN®’s dedication to advancing knowledge in botanical wellness through rigorous scientific research. The study assessed the effects of VIVAZEN®’s proprietary kratom extract on ad...
-

Unified Women’s Healthcare Responds to Rising Demand for Menopause Care

TAMPA, Fla.--(BUSINESS WIRE)--Unified Women’s Healthcare (Unified), in partnership with its OBGYN affiliates, is expanding access to perimenopause and menopause care nationwide through Unified for You, its patient resource platform and corresponding awareness campaign, which initially launched in Florida earlier this month. Recent data shows many women experience years of untreated menopause-related conditions before receiving appropriate care, highlighting the importance of timely counseling,...
-

The Cannabist Company Extends Forbearance Agreement With Senior Noteholders

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders (the “Forbearing Noteholders”) of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “...
-

Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Revenue of $75.1 million, with revenue per active earning coach of $4,664 Independent active earning coaches of 16,100 Net loss of $18.1 million, or $1.65 per diluted share ("EPS"), which includes the tax provision charge to establish a non-cash valua...
-

We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine diverse patients – who were all new to injectable aesthetics – over two years.1 This innovative initiative will offer a rare and authentic real-life perspective on the power of regenerative biostimulation to deliver personalized outcomes, and demonstrate how Sculptra adapts to dif...
-

Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform

LONDON--(BUSINESS WIRE)--Calla Lily Clinical Care, a women’s health-focused medical technology company, and Merck, a leading science and technology company, have entered a strategic collaboration to support the continued development of Callavid®, a novel platform for intravaginal drug delivery. The collaboration represents the first industry partnership for the Callavid technology. Callavid is a transformational leak-resistant medical device designed to address challenges associated with the se...
-

NextSense Launches Smartbuds, the World's First Truly Wireless EEG Earbuds — Brain-Sensing Technology That Actively Improves Sleep

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NextSense, a pioneer in brain-sensing wearable technology, today announced the official launch and commercial shipping of NextSense Smartbuds. Unlike sleep trackers that only monitor, Smartbuds use six EEG sensors to measure brain activity in real time — then respond with precisely timed audio stimulation to guide the brain into deeper, more restorative sleep. By transforming EEG from a clinical tool into an effortless consumer experience, NextSense redef...
-

The Cannabist Company Announces Closing of Transaction for the Sale of Virginia Assets to an Affiliate of Millstreet

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced the closing of the transaction, previously announced on December 18, 2025, to sell all of the ownership interests of its subsidiary engaged in the business of cultivating, producing, manufacturing, distributing and selling cannabis i...